Carbonic Anhydrase Inhibitors in the Treatment of Glaucoma. Review. Part I-Reference-Cited by-同舟云学术

Carbonic Anhydrase Inhibitors in the Treatment of Glaucoma. Review. Part I

Published:2020-11-13 Issue:3s Volume:17 Page:542-549
ISSN:2500-0845
Container-title:Ophthalmology in Russia
language:
Short-container-title:Oftalʹmologiâ

Author:

Kurysheva N. I.¹

Affiliation:

1. The Department of Eye Diseases at the Medical Biological University of Innovations and Continuing Education of the Federal Biophysical Center named after A.I. Burnazyan; Diagnostic Department of the Ophthalmological Center of Federal Medical‑Biological Agency of Russia, Clinical Hospital No. 86

Publisher

PE Polunina Elizareta Gennadievna

Subject

Ophthalmology

Reference80 articles.

1. Tham Y.C., Li X., Wong T.Y., Quigley H.A., Aung T., Cheng C.Y. Global prevalence of glaucoma and projections of glaucoma burden through 2040: a systematic review and meta‑analysis. Ophthalmology. 2014;121(11):2081–2090. DOI: 10.1016/j.ophtha.2014.05.013

2. Sharif N.A. Glaucomatous optic neuropathy treatment options: the promise of novel therapeutics, techniques and tools to help preserve vision. Neural Regen Res. 2018;13(7):1145–1150. DOI: 10.4103/1673‑5374.235017

3. Tomar J.S., Shen J. Characterization of Carbonic Anhydrase In Vivo Using Magnetic Resonance Spectroscopy. Int J Mol Sci. 2020;21(7):2442. DOI: 10.3390/ijms21072442

4. Supuran C.T. Carbonic anhydrases: novel therapeutic applications for inhibitors and activators. Nature Reviews Drug Discovery. 2008;7(2):168–181. DOI: 10.1038/nrd2467

5. Kinsey V.E. Comparative chemistry of aqueous humor in posterior and anterior chambers of rabbit eye, its physiologic significance. AMA Arch Ophthalmol. 1953;50(4):401–417. DOI: 10.1001/archopht.1953.00920030409001

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Normal-Tension Glaucoma: Epidemiology, Pathogenesis, Diagnosis and Treatment. Literature Review. Part 2. Role of Vascular Dysregulation in the Pathogenesis. Treatment of Normal Tension Glaucoma;Ophthalmology in Russia;2023-12-27

2. Development of the chromatographic separation methodology and impurity profiling of 5-(5-trifluoromethyl-isoxazol-3-yl)furan-2-sulfonamide, a drug candidate for the glaucoma treatment;From Chemistry Towards Technology Step-By-Step;2023-12-23

3. Development of the chromatographic separation methodology and impurity profiling of 5-(5-trifluoromethyl-isoxazol-3-yl)furan-2-sulfonamide, a drug candidate for the glaucoma treatment;From Chemistry Towards Technology Step-By-Step;2023-12-23

4. Pharmacotherapy of glaucoma in terms of evidence-based medicine;Kachestvennaya Klinicheskaya Praktika = Good Clinical Practice;2023-10-20

5. Pharmacological Properties of Sulfonamide Derivatives, New Inhibitors of Carbonic Anhydrase;Bulletin of Experimental Biology and Medicine;2023-06